Inventor · disambiguated record
Paul Delmar
Also filed as: DELMAR PAUL
1 granted patent·29 pending applications·0 citations·filing 2008–2014
13Inventor score
Top patents by PatentIndex Score
30 records- 0154US2014302019A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancerHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 0251US2013183303A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancerHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0351US2013121999A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancerHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 0451US2013183301A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancerHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0551US2013195857A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancerHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0651US2013183302A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of breast cancerHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0751US2013108626A1Blood plasma biomarkers for bevacizumab combination therapies for treatment of pancreatic cancerHOFFMANN LA ROCHE·Filed 2012·Application pending·0 cites
- 0850US2013315899A1Methods and compositions for diagnostic use in cancer patientsHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 0947US2013217713A1Predictive marker for egfr inhibitor treatmentHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1045US2013177554A1Neuropilin as a biomarker for bevacizumab combination therapiesHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1145US2014294768A1Responsiveness to angiogenesis inhibitorsHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 1245US2013183304A1Neuropilin as a biomarker for bevacizumab combination therapiesHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1345US2013171134A1Neuropilin as a biomarker for bevacizumab combination therapiesHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1442US2014099302A1Methods to identify responsive patientsHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1541US9121067B2Predictive marker for EGFR inhibitor treatmentHOFFMANN LA ROCHE·Filed 2013·Granted Sep 1, 2015·0 cites·1 claims
- 1640US2011064732A1Methods and compositions for diagnostic use in cancer patientsDE HAAS SANNE LYSBET·Filed 2010·Application pending·0 cites
- 1740US2011190321A1Predictive marker for egfr inhibitor treatmentDELMAR PAUL·Filed 2008·Application pending·0 cites
- 1839US2011184004A1Predictive marker for egfr inhibitor treatmentDELMAR PAUL·Filed 2008·Application pending·0 cites
- 1939US2011212979A1Predictive marker for egfr inhibitor treatmentDELMAR PAUL·Filed 2008·Application pending·0 cites
- 2039US2011245279A1Predictive marker for egfr inhibitor treatmentDELMAR PAUL·Filed 2008·Application pending·0 cites
- 2139US2011184005A1Predictive marker for egfr inhibitor treatmentDELMAR PAUL·Filed 2008·Application pending·0 cites
- 2239US2011312981A1Predictive marker for egfr inhibitor treatmentDELMAR PAUL·Filed 2008·Application pending·0 cites
- 2337US2013217712A1Predictive marker for egfr inhibitor treatmentHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 2436US2014294811A1Method for predicting risk of hypertension associated with anti-angiogenesis therapyHOFFMANN LA ROCHE·Filed 2014·Application pending·0 cites
- 2536US2011182892A1Methods to identify responsive patientsHOFFMANN LA ROCHE·Filed 2011·Application pending·0 cites
- 2634US2011218212A1Predictive markers for egfr inhibitors treatmentDELMAR PAUL·Filed 2008·Application pending·0 cites
- 2732US2012195858A1Responsiveness to angiogenesis inhibitorsFOERNZLER DOROTHEE·Filed 2010·Application pending·0 cites
- 2831US2011195982A1Predictive marker for egfr inhibitor treatmentDELMAR PAUL·Filed 2008·Application pending·0 cites
- 2931US2011230506A1Predictive marker for egfr inhibitor treatmentDELMAR PAUL·Filed 2008·Application pending·0 cites
- 3018US2012164639A1Methods for detecting low grade inflammationBOBADILLA MARIA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Paul Delmar files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →